Tirzepatide

Authoritative sources

• Wikidata (Q98955447)
• Wikipedia

Evidence base

• Randomized Controlled Trial · 2022 · Landmark

  Tirzepatide Once Weekly for the Treatment of Obesity

  New England Journal of Medicine · Jastreboff AM, Aronne LJ, Ahmad NN, et al. (SURMOUNT-1)

  The pivotal trial that established tirzepatide (Zepbound / Mounjaro) as the most effective medication studied for weight loss to date.

• Phase III Clinical Trial · 2025

  Tirzepatide as Compared with Semaglutide for the Treatment of Obesity

  The New England journal of medicine · Aronne LJ, Horn DB, le Roux CW, Ho W, et al.

• Randomized Controlled Trial · 2025

  Tirzepatide for Obesity Treatment and Diabetes Prevention

  The New England journal of medicine · Jastreboff AM, le Roux CW, Stefanski A, Aronne LJ, et al.

• Randomized Controlled Trial · 2025

  Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity

  The New England journal of medicine · Packer M, Zile MR, Kramer CM, Baum SJ, et al.

• Phase III Clinical Trial · 2025

  Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes

  The New England journal of medicine · Nicholls SJ, Pavo I, Bhatt DL, Buse JB, et al.

• Randomized Controlled Trial · 2024

  Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity

  The New England journal of medicine · Malhotra A, Grunstein RR, Fietze I, Weaver TE, et al.

• Randomized Controlled Trial · 2024

  Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial

  JAMA · Aronne LJ, Sattar N, Horn DB, Bays HE, et al.

• Systematic Review · 2024

  Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis

  BMJ (Clinical research ed.) · Yao H, Zhang A, Li D, Wu Y, et al.

• Randomized Controlled Trial · 2022

  Tirzepatide Once Weekly for the Treatment of Obesity

  The New England journal of medicine · Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, et al.

• Randomized Controlled Trial · 2021

  Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes

  The New England journal of medicine · Frías JP, Davies MJ, Rosenstock J, Pérez Manghi FC, et al.

Where Tirzepatide appears on Kindr Health